NEW YORK (GenomeWeb News) - GeneGo today said it has licensed its MetaCore technology to the Reproductive Medicine Associates of New Jersey.
The facility will use the tool to analyze gene-expression data in research and in their clinic. Julie Bryant, vice president of business development at GeneGo, said this is the first time MetaCore will be used by health-care practitioners instead of pharmaceutical companies or academic groups.
Financial details for the multi-year agreement were not disclosed.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A new study in JAMA finds that genetic tests might not be able to determine what diet is right for someone seeking to lose weight.

A genome-wide association study that linked common genetic variants to salivary gland carcinoma risk has been retracted, according to Retraction Watch.

Vampire bats' ability to live off blood is etched in their genomes and gut microbiomes, the Scientist reports.

In Genome Biology this week: peopling of the Sahara, epigenetic reprogramming analysis of liverwort, and more.

Sponsored by

This webinar will share how clinical genetics labs can integrate cytogenetics and molecular data to assess abnormalities using a single sample on a single workflow platform.